Search Results for 'alfred e. mann foundation'
-
Neurological
Axonics Granted Four U.S. Patents Related to its Implantable Sacral Neuromodulation Technology
The company's r-SNM System received European CE Mark approval in June 2016.Business Wire 03.07.17
-
Axonics Sacral Neuromodulation System Receives Marketing Approval from Health Canada
Company received ethics committee approval from the University of Toronto to treat patients in Canada.Business Wire 01.09.17
-
R&D & Design
Axonics Granted New U.S. Patent Related to its Implantable Neuromodulation Technology
Company has 61 issued and 85 pending patent applications in its portfolio.Business Wire 10.03.16
-
Axonics Sacral Neuromodulation System Receives MRI Conditional Labeling
European approval granted for 1.5T and 3T MRI scans.Businesswire 07.28.16
-
Axonics Announces First Patients Treated in Sacral Neuromodulation Study
Post-market study evaluates mini rechargeable system for overactive bladder patients.Business Wire 06.20.16
-
Axonics Granted Six U.S. Patents
Patents relate to implantable neuromodulation technology and recharging systems.Business Wire 05.11.16
